Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current thinking in statin therapy.

P Puddu1, G M Puddu, A Muscari

  • 1Department of Internal Medicine, Cardioangiology, Hepatology, University of Bologna, Italy.

Acta Cardiologica
|September 28, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanical properties and metallurgical features of new and ex vivo used Reciproc Blue and Reciproc.

International endodontic journal·2019
Same author

Clinical predictors of fever in stroke patients: relevance of nasogastric tube.

Acta neurologica Scandinavica·2015
Same author

A comparison of risk factors as predictors of cardiovascular and non-cardiovascular mortality in the elderly people--relevance of N-terminal pro-B-type natriuretic peptide and low systolic blood pressure.

International journal of clinical practice·2013
Same author

Skin reactions triggered by the use of cosmetic products in nonspecific lipid transfer protein-sensitive patients.

International journal of immunopathology and pharmacology·2011
Same author

A simple scoring system for outcome prediction of ischemic stroke.

Acta neurologica Scandinavica·2011
Same author

The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases.

International journal of clinical practice·2009
Same journal

Dialysis-related spontaneous anterior mediastinal hemorrhage.

Acta cardiologica·2026
Same journal

From the arrhythmia to the substrate: the role of atrial cardiomyopathy in atrial fibrillation management.

Acta cardiologica·2026
Same journal

Presence of anti-cardiac troponin I antibodies (cTnIAb) and their role in the left ventricular remodelling, in patients with acute myocardial infarction.

Acta cardiologica·2026
Same journal

Guideline-recommended medical therapy and clinical outcomes in cancer patients with de Novo heart failure.

Acta cardiologica·2026
Same journal

Association between red cell distribution width and all-cause mortality in patients with congestive heart failure and atrial fibrillation.

Acta cardiologica·2026
Same journal

The ventricular assist device outflow cannula anastomosis to the descending aorta in a patient with porcelain aorta.

Acta cardiologica·2026
See all related articles

Statins are potent drugs for lowering lipids and reducing coronary artery disease risks. Their benefits extend beyond cholesterol reduction, impacting inflammation and plaque stability.

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Biochemistry

Background:

  • HMG-CoA reductase inhibitors (statins) are primary lipid-lowering agents.
  • Statins significantly reduce coronary artery disease (CAD) morbidity and mortality.
  • Emerging evidence suggests statin benefits exceed simple LDL reduction.

Purpose of the Study:

  • To explore the non-lipid-lowering effects of statins.
  • To investigate the pleiotropic actions of statins in cardiovascular disease.
  • To highlight differences in these effects among various statin medications.

Main Methods:

  • Review of existing clinical and biochemical evidence on statin effects.
  • Analysis of studies examining endothelial function, LDL oxidation, and inflammation.

Related Experiment Videos

  • Comparative assessment of pleiotropic effects across different statins.

    • Main Results:

    • Statins demonstrate beneficial effects on endothelial dysfunction.
    • These drugs can inhibit LDL oxidation and modulate thrombogenic factors.
    • Statins influence cellular inflammation and impact atherosclerotic plaque stability.
    • Variability exists among statins regarding these non-lipid-associated effects.

    Conclusions:

    • Statin-mediated clinical benefits are not solely due to LDL reduction.
    • Pleiotropic effects, including anti-inflammatory and plaque-stabilizing actions, contribute significantly.
    • Understanding these diverse biochemical effects is crucial for optimizing statin therapy.